How Much Pregnenolone Should a Woman Take Daily?

There is no established, evidence-based daily dose of pregnenolone for women. No government health agency has set a recommended intake, no FDA-approved pregnenolone drug exists, and the clinical trials that do exist have mostly used doses far higher than what you’ll find on supplement shelves. Over-the-counter products typically contain anywhere from 5 mg to 100 mg per capsule, but those numbers reflect market convention and manufacturer preference, not clinical evidence tailored to women’s health.

What Doses Have Actually Been Studied

Most of the rigorous clinical research on pregnenolone has used doses in the range of 300 to 500 mg per day, split into two doses. A pilot study examining oral pregnenolone found that both 300 mg/day and 500 mg/day produced significantly elevated plasma levels compared to placebo, and the two dose groups achieved similar circulating levels, suggesting that going higher did not meaningfully increase how much pregnenolone ended up in the bloodstream.¹ A separate trial studying pregnenolone for bipolar depression also used 500 mg/day and reported that it could be safely administered over the study period.²

These doses are dramatically higher than what most supplement brands sell. If you pick up a bottle of pregnenolone at a health food store, it likely contains 10 mg or 25 mg per capsule. The gap between supplement-shelf doses and clinical-trial doses is enormous, and neither end of that range has been validated as the right amount for general wellness in women. The low doses lack formal study; the high doses were tested in narrow clinical populations for specific psychiatric conditions, not as daily wellness supplements.

Why No Official Dose Exists

Pregnenolone occupies a regulatory gray area. It is sold as an over-the-counter dietary supplement marketed for neurological and immune health, but there are no FDA-approved pregnenolone drugs.³ Compounded pregnenolone preparations are available through pharmacies, but even these lack a standardized monograph for evaluating product quality, which raises the possibility of inconsistent dosing from one batch or brand to the next.³

Without large-scale, long-term trials in healthy women, no medical body has been willing to issue dosing recommendations. The trials that do exist enrolled small samples, ran for relatively short periods (typically eight weeks or less), and focused on psychiatric or substance-use conditions. Extrapolating those findings to a 45-year-old woman hoping to support her energy or mood is a stretch the evidence does not support yet.

How Pregnenolone Levels Change With Age in Women

Your body makes pregnenolone from cholesterol inside the mitochondria of cells in the adrenal glands, ovaries, and brain.⁴ It serves as the starting material for nearly every steroid hormone your body produces, including progesterone, DHEA, cortisol, estrogen, and testosterone. This is why it is sometimes called the “mother hormone.”

In women, circulating pregnenolone sulfate levels peak around age 32 and then decline continuously from that point onward.⁵ This pattern is notably different from men, whose levels peak about five years earlier but then remain relatively stable rather than continuing to fall. The steady decline in women is one reason pregnenolone supplementation is marketed so heavily toward women in midlife and beyond, though the logic that “levels drop, so supplementing must help” oversimplifies what is happening. A declining level does not automatically mean that topping it off with a pill restores the same downstream hormone balance your body once maintained on its own.

What Pregnenolone Does Beyond Hormone Production

Pregnenolone is not just a passive raw material waiting to be converted into other hormones. It and its metabolites act directly in the brain as neurosteroids. Research has shown beneficial effects in the brain, including influences on memory, learning, and cognitive function, and decreased pregnenolone levels have been observed in neuroinflammatory diseases.⁶ One of its sulfated forms, pregnenolone sulfate, can reduce the activity of GABA-A receptors, the same receptors targeted by anti-anxiety medications and sleep aids.⁷ This receptor-blocking activity is significant because it means pregnenolone is not simply a building block; it has its own pharmacological footprint in the nervous system.

One small human study found that pregnenolone increased time spent in slow-wave sleep, the deep, restorative phase of sleep.⁸ This is an interesting wrinkle because it suggests that pregnenolone’s relationship to sleep is not straightforward. Blocking GABA-A receptors is typically associated with alertness, yet the sleep data point in the opposite direction for overall sleep depth. The science here is genuinely unsettled, and anyone taking pregnenolone for sleep should know that the evidence base is thin and somewhat contradictory.

Research on Mood and Stress

The most developed area of pregnenolone research, and the area most relevant to dose, involves mood and stress-related conditions. In a randomized, placebo-controlled trial of people with bipolar depression, pregnenolone at 500 mg/day led to higher depression remission rates: about 61% in the pregnenolone group compared with 37% in the placebo group on one depression scale. Changes in anxiety also correlated with changes in pregnenolone’s metabolites, suggesting the mood effects were tied to how the body processed pregnenolone downstream.²

A separate study examined pregnenolone’s effects on the stress-response system. Both 300 mg and 500 mg daily doses normalized a key marker of overall stress-hormone regulation that was blunted in the placebo group. The 300 mg group specifically showed a significantly improved cortisol-to-ACTH ratio in response to stress compared to placebo.⁹ These findings are compelling but limited. Both studies involved people with diagnosed conditions, and neither studied healthy women looking for general wellness support. The doses used were also many times higher than what is typically sold as a supplement.

Hormone-Sensitive Risks Women Should Know About

Because pregnenolone sits at the top of the steroid hormone cascade, supplementing with it does not just raise pregnenolone levels. It can also increase levels of downstream hormones, including estrogen, progesterone, and testosterone. This is not a theoretical concern. If you are already taking medications that contain estrogen, progesterone, progestin, or testosterone, adding pregnenolone could result in hormonal imbalance or excess levels of those hormones.

For postmenopausal women, the picture gets more complicated. A study of postmenopausal women examined the relationship between circulating levels of pregnenolone-related metabolites and cancer risk. Higher levels of 17-hydroxypregnenolone, a direct metabolite of pregnenolone, were associated with a lower risk of endometrial cancer but a higher risk of ovarian cancer.¹⁰ This does not prove that taking pregnenolone supplements causes ovarian cancer, since the study measured the body’s own hormone levels rather than supplement use. But it does flag that the relationship between pregnenolone metabolites and hormone-sensitive cancers is not uniformly reassuring, and women with a personal or family history of ovarian cancer should approach supplementation with extra caution.

Women with a history of breast cancer, endometriosis, uterine fibroids, or other hormone-sensitive conditions face similar uncertainty. No trials have specifically assessed the safety of pregnenolone supplementation in these groups. Given that the entire point of pregnenolone is to feed into other hormones, the absence of safety data in hormone-sensitive populations is a real gap, not a technicality.

Drug Interactions Worth Watching

Pregnenolone’s activity at GABA-A receptors has practical consequences if you take certain medications. A small study found that people pretreated with chronic pregnenolone showed significantly less sedation following diazepam (a benzodiazepine), and the effect was clinically apparent, meaning it was visible to observers, not just a statistical blip.¹¹ If you rely on a benzodiazepine for sleep or anxiety management, adding pregnenolone could undermine its effectiveness. This is not a minor interaction for people who depend on these medications to function.

Beyond benzodiazepines, any hormone-containing medication warrants a conversation with your prescriber before adding pregnenolone. Hormonal birth control, hormone replacement therapy, and testosterone treatments could all be affected because pregnenolone’s metabolic products overlap with the same hormones those medications are designed to regulate. The risk is not necessarily dangerous side effects, though those are possible. It is more that the careful hormonal balance your medication was calibrated to achieve could be thrown off in ways that are hard to predict without blood work.

The Product Quality Problem

Even if you settle on a dose that seems reasonable, you face a practical problem: the pregnenolone in your bottle may not match what’s on the label. Because no United States Pharmacopeia monograph exists for pregnenolone, there is no standardized method that manufacturers are required to use when testing the identity, purity, or potency of their products.³ This applies to both over-the-counter supplements and compounded pharmacy preparations. Some products may contain less pregnenolone than claimed, some may contain more, and some may contain contaminants.

Third-party testing services like USP Verified, NSF International, and ConsumerLab do test supplements for label accuracy, but pregnenolone products are not always included in their testing programs. If you are going to supplement, choosing a product from a manufacturer that voluntarily submits to third-party testing is one of the few concrete steps you can take to reduce uncertainty about what you’re actually putting in your body.

What Practitioners Typically Recommend in Practice

Despite the absence of clinical guidelines, a loose consensus has emerged among integrative and functional medicine practitioners. Most start women at doses between 5 mg and 30 mg per day, monitor symptoms and blood work, and adjust from there. Some practitioners use pregnenolone specifically to support progesterone levels in perimenopausal women with low progesterone metabolites, sometimes combining it with other nutritional interventions rather than using it as a standalone supplement.¹²

This approach is reasonable in spirit: start low, monitor, and adjust. But it is based on clinical experience and pattern recognition rather than controlled trials. Two women of the same age with similar symptoms might respond very differently to the same dose because pregnenolone can be converted into different hormones depending on which enzymes are most active in a given person’s body. One woman might convert it primarily toward progesterone; another might shunt more toward DHEA and then testosterone or estrogen. Without testing, you’re guessing which pathway your body will favor.

Why “Start Low and Go Slow” Is Not Just a Cliché Here

The usual supplement advice to start with a low dose takes on extra weight with pregnenolone because of that branching metabolic pathway. Unlike supplementing with, say, vitamin D, where the body handles one molecule with a relatively predictable route, pregnenolone can become many different things. A dose that mildly supports mood in one person could push another toward acne, oily skin, or irritability if their body preferentially converts it to androgens. Some women report breast tenderness or menstrual irregularity after starting pregnenolone, which likely reflects downstream estrogen or progesterone shifts.

Blood work before starting and again four to six weeks in gives you the clearest picture. A comprehensive hormone panel that includes pregnenolone, DHEA-S, progesterone, estradiol, testosterone, and cortisol can show where your baseline sits and whether supplementation is shifting things in the direction you intended. Without that data, any dose is a stab in the dark, particularly for women in perimenopause or menopause, when hormonal shifts are already in motion and adding an upstream precursor introduces another variable.

Pregnenolone and the Oral Bioavailability Question

One practical detail that matters for dosing: how much of what you swallow actually reaches your bloodstream? Early skepticism about oral pregnenolone centered on concerns that it would be heavily broken down in the gut and liver before reaching circulation. Research has pushed back on that concern. The pilot study that tested 300 mg and 500 mg daily doses found that both achieved stable, reliably elevated plasma pregnenolone levels over more than 32 hours, supporting good bioavailability when taken orally twice a day.¹

That said, these findings come from doses far beyond what most supplement users take. Whether 10 mg or 25 mg per day achieves meaningful elevation in blood levels has simply not been studied with the same rigor. Some practitioners use sublingual (under-the-tongue) or micronized formulations in hopes of improving absorption at lower doses, but head-to-head comparisons between delivery methods at supplement-level doses are lacking. The honest answer is that at the doses most women actually take, we do not have good data on how efficiently the supplement gets into circulation.

When Pregnenolone Probably Is Not the Right Choice

Certain situations make pregnenolone supplementation riskier or less logical than others. Women who are pregnant or breastfeeding should avoid it entirely, as no safety data exist for these populations and the potential to alter fetal or infant hormone exposure is obvious. Women with active hormone-sensitive cancers or a strong family history of ovarian cancer face a risk-benefit equation that leans heavily toward caution, given the association between pregnenolone metabolites and ovarian cancer risk in postmenopausal women.¹⁰

Women taking benzodiazepines for anxiety or insomnia should be aware of the documented interaction that can reduce the medication’s effectiveness.¹¹ And women on carefully calibrated hormone therapy, whether for menopause symptoms, endometriosis, or gender-affirming care, risk disrupting that balance by adding an upstream precursor hormone that their body may convert in unpredictable directions. In all of these cases, the right move is to discuss pregnenolone with the clinician managing the existing condition rather than self-prescribing.